Clinical Implementation of CGM in the Community Pharmacy

The American Pharmacists Association (APhA) developed The Clinical Implementation of Continuous Glucose Monitoring in the Community Pharmacy Certificate Training Program, an educational experience designed to equip pharmacists with the knowledge, skills, and confidence needed to perform CGM services. The program has both an online home study component, as well as a 4-hour live program.

The program provides comprehensive instruction in current CGM concepts and standards of care and incorporates case studies and hands-on skills training focused on the situations most likely to be encountered—as well as the services most needed—in community practice settings. Participants will gain experience in the clinical and operational aspects of CGM, including but not limited to workflow, billing, patient identification, patient education, visit guides, and documentation processes.

Pricing

Member Price: $249
Nonmember Price: $499

If your company or organization is interested in offering this program to your pharmacists and/or student pharmacists, please contact Chris McKerrow.

Learning Objectives & Module Details

Home Study

This course contains the following contents:

Clinical Implementation of CGM in the Community Pharmacy ACPE Information
Clinical Implementation of CGM in the Community Pharmacy Contributors List
Clinical Implementation of CGM in the Community Pharmacy Pre-Assessment
Module 1: Introduction to continuous glucose monitoring
Module 2: Continuous glucose monitoring devices
Module 3: Evolution of continuous glucose monitoring: Integration with insulin delivery
Module 4: Continuous glucose monitoring targets and reports
Module 5: Troubleshooting continuous glucose monitoring technology
Module 6: Medication adjustment and patient education based on continuous glucose monitoring data
Module 7: Billing for continuous glucose monitoring and services
Module 8: Continuous glucose monitoring business planning
Module 9: Optimizing continuous glucose monitoring access and efficiency
Clinical Implementation of CGM CTP Home Study Assessment
APhA Education Evaluation

Module 1: Introduction to Continuous Glucose Monitoring

At the completion of this activity, participants will be able to:

Describe the importance of achieving glucose targets in people with types 1 and 2 diabetes (T1D and T2D).
Compare and contrast traditional blood glucose monitoring, hemoglobin A1C, and continuous glucose monitoring (CGM) and the role each plays in patient care.
Discuss the clinical value of CGM for people living with diabetes.
Identify individuals that would benefit from CGM based on current clinical practice guidelines.
Recall key outcomes data supporting use of CGM in select populations.

Module 2: Continuous Glucose Monitoring Devices

At the completion of this activity, participants will be able to:

Recognize continuous glucose monitoring (CGM) device types and components.
Compare and contrast currently available CGM devices.
Identify device- and patient-specific factors for selecting a CGM device.
Describe appropriate steps to operate and retrieve data from CGM devices.

Module 3: Evolution of Continuous Glucose Monitoring: Integration with Insulin Delivery

At the completion of this activity, participants will be able to:

Describe available insulin delivery systems that integrate with continuous glucose monitoring (CGM).
Differentiate features of connected insulin pens and how they may be applied in clinical practice to optimize insulin therapy.
Explain automated insulin delivery (AID) via pump systems that integrate with CGM.
Discuss evidence on clinical outcomes for AID systems in people with diabetes.

Module 4: Continuous Glucose Monitoring Targets and Reports

At the completion of this activity, participants will be able to:

Discuss key continuous glucose monitoring metrics and time in range (TIR) guidelines for multiple types of people with diabetes.
Interpret continuous glucose monitoring (CGM) key metrics and Ambulatory Glucose Profile (AGP) reports.

Module 5: Troubleshooting Continuous Glucose Monitoring Technology

At the completion of this activity, participants will be able to:

Identify potential user error and troubleshooting needed with continuous glucose monitoring (CGM) data.
Discuss strategies to assist patients in resolving CGM-related issues.

Module 6: Medication Adjustment and Patient Education Based on CGM Data

At the completion of this activity, participants will be able to:

Describe the DATAA model and how it can be used to facilitate shared decision making.
Use the DATAA model to interpret CGM data and adjust treatment regimens.
Apply CGM best practices through a series of patient cases.
Demonstrate effective strategies for communicating the data report to the patient.

Module 7: Billing for Continuous Glucose Monitoring and Services

At the completion of this activity, participants will be able to:

Identify available pharmacy payors for continuous glucose monitoring (CGM) devices.
Identify opportunities for pharmacy payment for pharmacist-delivered CGM services.
Describe best practices in billing for CGM devices and pharmacist-delivered CGM services.

Module 8: Continuous Glucose Monitoring Business Planning

At the completion of this activity, participants will be able to:

Identify community and pharmacy-based metrics to utilize to evaluate potential plausibility from CGM services in your pharmacy.
Describe the start-up process for CGM service delivery.
Construct an effective, efficient pharmacy workflow for CGM service delivery.
Recognize best practices and resources for staff training prior to CGM service delivery.
Discuss marketing considerations for CGM service delivery.

Module 9: Optimizing CGM Access and Efficiency

At the completion of this activity, participants will be able to:

Describe the challenges and barriers to access for the effective use of continuous glucose monitoring.
List examples of legislation related to pharmacists providing CGM services.

Live Program

At the completion of this practice-based activity, participants will be able to:

Discuss an effective approach for identifying patients that may benefit from continuous glucose monitoring (CGM) services from your pharmacy.
Operate a variety of CGM devices appropriately.
Identify and troubleshoot potential issues with CGM device attachment.
Analyze CGM reports and provide clinical recommendations based on CGM data.
Practice educating patients based on CGM data using shared decision-making and motivational interviewing principles.
Summarize CGM-related recommendations effectively for interdisciplinary providers and patients.
Outline an implementation plan for CGM services in your pharmacy.

How to Obtain a Certificate of Completion

Complete 9 self-study modules, each of which consists of an interactive eLearning module, podcast, and/or webinar and achieve a passing grade of 70% or higher on the self-study assessment.
Attend the full live seminar and achieve a passing grade of 70% or higher on the final assessment.
Complete all course evaluations.
Credit must be claimed for each course (self-study, live seminar, and post-live training) in order to obtain credit.
Participants will need to have a valid APhA (pharmacist.com) username and password, as well as a CPE Monitor account to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
The Certificate of Completion will be available online upon successful completion of all activities on the participant’s My Training page.
APhA continuing pharmacy education policy provides you with two opportunities to successfully complete a continuing pharmacy education assessment. Please note that you will not be permitted to submit an assessment a third time. The current policy of the APhA Education Department is not to release the correct answers to any of our CPE tests. This is intended to maintain the integrity of the CPE activity and the assessment.

Accreditation Information

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. APhA's Clinical Implementation of CGM in the Community Pharmacy is approved for a total of 12.0 contact hours of continuing pharmacy education (CPE) credit (1.2 CEUs). The ACPE Universal Activity Numbers (UAN) for this activity are listed below.

Self-study component is approved for 8 hours (0.8 CEUs) of CPE credit. ACPE UAN 0202-0000-24-260-H01-P
Live component is approved for 4 hours (0.4 CEUs) of CPE credit. ACPE UAN: 0202-0000-24-261-L01-P / 0202-9999-24-261-L01-P
Activity Type: Certificate Program
Target Audience: Pharmacists
Release Date: July 1, 2024
Expiration Date: July 1, 2027 - PLEASE NOTE: NO Home Study credit granted after this date. Live Credit can only be granted within 60 days of the day of the session attended.

Technology Requirements and Tips

Computer and Internet access are required to complete this activity. If you experience technical difficulties, try a different web browser.

Please be aware that if the system detects no activity for an extended amount of time while the screen is open in the interactive activity, the Next button may freeze, and you will need to Restart that activity again.

The recommendation is that if you cannot complete the activity within one sitting and need to step away, close the activity so that your place is bookmarked.

If you continue to experience difficulties, please reach out to education@aphanet.org with the name of course, details of your experience, which web browser(s) used and if possible, screenshots.

Faculty

Advisory Board

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP

Endocrine Clinical Pharmacy Specialist, Co-Director, Endocrine Disorders in Pregnancy
Cleveland Clinic Endocrinology & Metabolism Institute
Cleveland, OH

Disclosures: Speaker: Dexcom, Abbott, Medtronic, Insulet, Novo Nordisk, Cequr, Mannkind, Sanofi, and Lilly

Lindsey Miller, PharmD

Clinical Assistant Professor
University of Mississippi School of Pharmacy
Oxford, MS

Disclosure: Author has nothing to disclose

Nicole C. Pezzino, PharmD, BCACP, BC-ADM, CDCES

Clinical Pharmacy Consultant
RedSail Technologies
Allentown, PA

Disclosure: Author has nothing to disclose

Authors

Betsy Blake, PharmD, BCPS, FNAP

Clinical Associate Professor and Director of Interprofessional Education
College of Pharmacy, University of South Carolina
Lexington, SC

Disclosure: Grant recipient: Abbott Diabetes Care - medical education grant

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP

Endocrine Clinical Pharmacy Specialist, Co-Director, Endocrine Disorders in Pregnancy
Cleveland Clinic Endocrinology & Metabolism Institute
Cleveland, OH

Disclosures: Speaker: Dexcom, Abbott, Medtronic, Insulet, Novo Nordisk, Cequr, Mannkind, Sanofi, and Lilly

Kevin Malloy, PharmD, BCPS, BC-ADM, CDCES

Endocrine Clinical Pharmacy Specialist
Cleveland Clinic Endocrinology & Metabolism Institute
Lakewood, OH

Disclosure: Author has nothing to disclose

Caroline Miller Yon, PharmD, AAHIVP, CPP

Clinical Pharmacist, Primary Care
Novant Health
Charlotte, NC

Disclosure: Author has nothing to disclose

Lindsey Miller, PharmD

Clinical Assistant Professor
University of Mississippi School of Pharmacy
Oxford, MS

Disclosure: Author has nothing to disclose

Taylor Pennisi, PharmD, BCACP, BC-ADM

Clinical Pharmacist, DSMES Program Coordinator
Aiken Physicians Alliance
Aiken, SC

Disclosure: Author has nothing to disclose

Nicole C. Pezzino, PharmD, BCACP, BC-ADM, CDCES

Clinical Pharmacy Consultant
RedSail Technologies
Allentown, PA

Disclosure: Author has nothing to disclose

Ebne Rafi, PharmD, BCACP, RPh

Clinical Pharmacy Specialist
University Hospitals Diabetes & Metabolic Care Center
Willoughby, OH

Disclosure: Author has nothing to disclose

Sara (Mandy) Reece, PharmD, CDCES, BC-ADM, BCACP, FADCES, FCCP

Associate Professor, Pharmacy Practice
Philadelphia College of Osteopathic Medicine (PCOM) Georgia
Gainesville, GA

Disclosures: Speaker and consultant: Dexcom and Novo Nordisk

Olivia Schad, PharmD

Clinical Pharmacist
Novant Health Huntersville Medical Center
Morrisville, NC

Disclosure: Author has nothing to disclose

Development

The Clinical Implementation of CGM in the Community Pharmacy CTP is an education activity for pharmacists developed by the American Pharmacists Association and supported by an educational grant from The Leona M. and Harry B. Helmsley Charitable Trust. © 2024 American Pharmacists Association.

APhA's Education staff involved in the review of this content declare no conflict of interest or financial interest in any product or service mentioned, including grants, employment, gifts, stock holdings, and honoraria. For a full listing of APhA Staff Disclosures, please see the APhA Disclosure Statement webpage at APhA Staff Disclosures.

Tags:

Advanced Training Education